Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

计划入组 50 人 · 首次发布于 2020 年 7 月 7 日

HRS-AKI Treatment With TIPS in Patients With Cirrhosis

计划入组 124 人 · 首次发布于 2022 年 4 月 26 日

Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.

计划入组 70 人 · 首次发布于 2020 年 6 月 4 日

AKi

AKI-2

AKI-1

ARS PHARMACEUTICALS

India

RHS CORP.

United States

HBS HOLDING AHMED

Morocco

Mallinckrodt to Present Five Clinical Studies on TERLIVAZ for Hepatorenal Syndrome at DDW 2025

Mallinckrodt to Present New Terlipressin Data at Kidney Week 2025 for Hepatorenal Syndrome Treatment

Tailored EHR Alerts Fail to Improve AKI Management in Hospitalized Patients: KAT-AKI Trial